why Editas Medicine Inc [EDIT] is a Good Choice for Investors After New Price Target of $3.25
Editas Medicine Inc [NASDAQ: EDIT] jumped around 2199997.75 points on Wednesday, while shares priced at $2200000.0 at the close of the session, up 13.78%. Editas Medicine Inc stock is now -45.18% down from its year-to-date (YTD) trading value. EDIT Stock saw the intraday high of